Clinical Trial Update: A Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating TRV027 in patients hospitalized for acute decompensated heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• TRV027

Snippet

Sponsor: Trevena Inc. | Conditions: Acute Decompensated Heart Failure | Phase 2 | Status: COMPLETED